𝔖 Bobbio Scriptorium
✦   LIBER   ✦

2236 SERUM CALCIUM AS A PROTECTIVE MARKER AGAINST PROSTATE CANCER:

✍ Scribed by Pourmand, Gholamreza; Hosseini, Mostafa; Salem, Sepehr; Allameh, Farzad; Nikoobakht, Mohammadreza; Mehrsai, Abdolrasoul; Dehghani, Sanaz; Heydari, Fariba

Book ID
123403814
Publisher
Lippincott Williams and Wilkins
Year
2012
Tongue
English
Weight
47 KB
Volume
187
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Endoglin (CD105) as a urinary and serum
Endoglin (CD105) as a urinary and serum marker of prostate cancer
✍ Kazutoshi Fujita; Charles M. Ewing; David Y.S. Chan; Leslie A. Mangold; Alan W. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 105 KB

## Abstract We have previously shown that endoglin (CD105) is upregulated in prostatic fluid of men with large volume prostate cancer. We chose to assess endoglin levels in urine and serum from men with prostate cancer or at increased risk for the disease: Urine samples were collected after digital

Haptoglobin-Ξ² chain defined by monoclona
Haptoglobin-Ξ² chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancer
✍ Seiichi Saito; Yasuko Murayama; Yuzhuo Pan; Takenobu Taima; Tsutomu Fujimura; Ki πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 773 KB

## Abstract In our previous study, monoclonal antibody RM2, established toward the glycosyl epitope, reflected grade of malignancy of prostate cancer cells whereas RM2 reactivity to benign glands was negative or weak. RM2 reactivity was also detected in stroma, suggesting the glycoprotein RM2 recog